Telum Therapeutics develops novel antimicrobial therapies targeting multidrug-resistant hospital-acquired and ventilator-associated bacterial pneumonia.
Create a free EquityFlow account to see Telum Therapeutics's 1 funding round, 6 investors, 12 similar companies.
Sign up free → Sign in